Journal of Neuroinflammation,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: Sept. 3, 2024
Alzheimer's
disease
(AD)
is
the
leading
form
of
dementia,
characterized
by
accumulation
and
aggregation
amyloid
in
brain.
Transient
receptor
potential
vanilloid
2
(TRPV2)
an
ion
channel
involved
diverse
physiopathological
processes,
including
microglial
phagocytosis.
Previous
studies
suggested
that
cannabidiol
(CBD),
activator
TRPV2,
improves
amyloid-β
(Aβ)
phagocytosis
TRPV2
modulation.
However,
molecular
mechanism
Aβ
remains
unknown.
In
this
study,
we
aimed
to
investigate
involvement
underlying
mechanisms.
Utilizing
human
datasets,
mouse
primary
neuron
microglia
cultures,
AD
model
mice,
evaluate
expression
both
vivo
vitro.
was
expressed
cortex,
hippocampus,
microglia.Cannabidiol
(CBD)
could
activate
sensitize
channel.
Short-term
CBD
(1
week)
injection
intraperitoneally
(i.p.)
reduced
neuroinflammation
phagocytic
receptors,
but
long-term
(3
administration
induced
suppressed
receptors
APP/PS1
mice.
Furthermore,
hyper-sensitivity
mediated
tyrosine
phosphorylation
at
sites
Tyr(338),
Tyr(466),
Tyr(520)
protein
kinase
JAK1,
these
mutation
partially
dependence
on
its
localization.
While
palmitoylated
Cys
277
site
blocking
palmitoylation
improved
Moreover,
it
demonstrated
dynamically
regulated
ZDHHC21.
Overall,
our
findings
elucidated
intricate
interplay
between
phosphorylation/dephosphorylation
cysteine
palmitoylation/depalmitoylation,
which
had
divergent
effects
These
provide
valuable
insights
into
mechanisms
linking
sensitivity,
offer
therapeutic
strategies
for
managing
AD.
Cell Reports Medicine,
Journal Year:
2023,
Volume and Issue:
4(4), P. 101005 - 101005
Published: April 1, 2023
To
develop
therapies
for
Alzheimer's
disease,
we
need
accurate
in
vivo
diagnostics.
Multiple
proteomic
studies
mapping
biomarker
candidates
cerebrospinal
fluid
(CSF)
resulted
little
overlap.
overcome
this
shortcoming,
apply
the
rarely
used
concept
of
proteomics
meta-analysis
to
identify
an
effective
panel.
We
combine
ten
independent
datasets
identification:
seven
from
150
patients/controls
discovery,
one
dataset
with
20
down-selection,
and
two
494
validation.
The
discovery
results
21
down-selection
three,
be
validated
additional
large-scale
228
diseased
266
control
samples.
This
resulting
3-protein
panel
differentiates
disease
(AD)
controls
validation
cohorts
areas
under
receiver
operating
characteristic
curve
(AUROCs)
0.83
0.87,
respectively.
study
highlights
value
systematically
re-analyzing
previously
published
data
more
stringent
deposition.
DOAJ (DOAJ: Directory of Open Access Journals),
Journal Year:
2022,
Volume and Issue:
3
Published: Jan. 1, 2022
Alzheimer
disease
is
one
of
the
most
challenging
demons
in
our
society
due
to
its
very
high
prevalence
and
clinical
manifestations
which
cause
deterioration
cognition,
intelligence,
emotions
-
capacities
that
distinguish
Homo
sapiens
from
other
animal
species.
Besides
personal,
social,
economical
costs,
late
stages
AD
are
vivid
experiences
for
family,
relatives,
friends,
general
observers
progressive
ruin
an
individual
who
turns
into
a
being
with
lower
mental
physical
than
less
evolved
A
human
brain
healthy
conscience,
can
succeed
dealing
difficulties
life
may
pose.
Without
these
capacities,
same
person
probably
cannot.
Due,
part,
this
emotional
impact,
absorbing
study
has
generated,
over
years,
fascinating
complex
story
theories,
hypotheses,
controversies,
fashion
swings,
passionate
clashes,
together
tremendous
efforts
achievements
geared
improve
understanding
pathogenesis
treatment
disorder.
Familal
rare
linked
altered
genetic
information
associated
three
genes.
Sporadic
(sAD)
much
more
common
multifactorial.
major
point
discussion
been,
still
is,
establishing
differences
between
aging
sAD.
This
not
trivial
question,
as
neuropathological
molecular
characteristics
normal
first
appearance
early
sAD-related
pathology
easily
distinguishable
individuals.
Another
important
confidence
assigning
responsibility
beginning
sAD
few
triggering
molecules,
without
considering
wide
number
alterations
converge
Genetic
risk
factors
covering
multiple
signals
increasing
number.
In
line,
pathways
at
pathology,
currently
grouped
under
aegis
aging,
only
increase
massively
advanced
process.
here
considered
inherent,
natural
part
prevalent
all
humans,
variably
present
or
individuals
The
progression
process
devastating
effects
relatively
low
percentage
beings
eventually
evolving
dementia.
continuum
implies
search
different
approach
biological
process,
advances
use
new
technologies
aimed
slowing
down
defects
underlying
outset,
transfering
tasks
AI
coordinated
devices.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: March 23, 2024
Abstract
Whole-body
physical
exercise
has
been
shown
to
promote
retinal
structure
and
function
preservation
in
animal
models
of
degeneration.
It
is
currently
unknown
how
modulates
inflammatory
responses.
In
this
study,
we
investigated
cytokine
alterations
associated
with
neuroprotection
induced
by
voluntary
running
wheel
a
degeneration
mouse
model
class
B1
autosomal
dominant
retinitis
pigmentosa,
I307N
Rho
.
mice
undergo
rod
photoreceptor
when
exposed
bright
light
(induced).
Our
data
show,
active
exhibited
significant
visual
compared
inactive
after
4
weeks
exercise.
Retinal
expression
revealed
reductions
proinflammatory
chemokines,
keratinocyte-derived
chemokine
(KC)
interferon
gamma
inducible
protein-10
(IP-10)
groups
groups.
Through
immunofluorescence,
found
KC
IP-10
labeling
localized
vasculature
marker,
collagen
IV.
These
show
that
whole-body
lowers
specific
vasculature.
Future
studies
should
determine
whether
suppression
responses
requisite
for
exercise-induced
protection.
Journal of Neuroinflammation,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: Sept. 3, 2024
Alzheimer's
disease
(AD)
is
the
leading
form
of
dementia,
characterized
by
accumulation
and
aggregation
amyloid
in
brain.
Transient
receptor
potential
vanilloid
2
(TRPV2)
an
ion
channel
involved
diverse
physiopathological
processes,
including
microglial
phagocytosis.
Previous
studies
suggested
that
cannabidiol
(CBD),
activator
TRPV2,
improves
amyloid-β
(Aβ)
phagocytosis
TRPV2
modulation.
However,
molecular
mechanism
Aβ
remains
unknown.
In
this
study,
we
aimed
to
investigate
involvement
underlying
mechanisms.
Utilizing
human
datasets,
mouse
primary
neuron
microglia
cultures,
AD
model
mice,
evaluate
expression
both
vivo
vitro.
was
expressed
cortex,
hippocampus,
microglia.Cannabidiol
(CBD)
could
activate
sensitize
channel.
Short-term
CBD
(1
week)
injection
intraperitoneally
(i.p.)
reduced
neuroinflammation
phagocytic
receptors,
but
long-term
(3
administration
induced
suppressed
receptors
APP/PS1
mice.
Furthermore,
hyper-sensitivity
mediated
tyrosine
phosphorylation
at
sites
Tyr(338),
Tyr(466),
Tyr(520)
protein
kinase
JAK1,
these
mutation
partially
dependence
on
its
localization.
While
palmitoylated
Cys
277
site
blocking
palmitoylation
improved
Moreover,
it
demonstrated
dynamically
regulated
ZDHHC21.
Overall,
our
findings
elucidated
intricate
interplay
between
phosphorylation/dephosphorylation
cysteine
palmitoylation/depalmitoylation,
which
had
divergent
effects
These
provide
valuable
insights
into
mechanisms
linking
sensitivity,
offer
therapeutic
strategies
for
managing
AD.